Kimberly-Clark to Acquire Kenvue
Kimberly-Clark has announced a cash and stock acquisition of Kenvue, the maker of Tylenol, valued at approximately $48.7 billion.
Merger Details
Upon completion, Kimberly-Clark shareholders will own about 54% of the combined company, while Kenvue shareholders will hold 46%.
Combined Brands
The merger brings together a broad array of popular consumer brands, including:
- Kenvue’s Tylenol, Listerine, and Band-Aid
- Kimberly-Clark’s Cottonelle, Huggies, and Kleenex
“We will serve billions of consumers across every stage of life.” - Mike Hsu, Kimberly-Clark Chairman and CEO
Author's summary: Kimberly-Clark acquires Kenvue for $48.7 billion.
More News
- Voting on Tuesday, the old-fashioned way
- Bridget Phillipson must not abandon special needs children | The Spectator Australia
- Jude Bellingham shares why he really thinks Liverpool fans booed Trent Alexander-Arnold
- Vintage Blakeman – your man in NYC
- Suffolk voters [reject/approve] ballot measure extending length of county legislative terms
- COMMENTARY: Suwannee’s centennial season a year to forget | Lake City Reporter
- Mamdani prevails in New York City mayoral race
- Why Are Some European Drug Gangs Burying Cocaine Instead of Selling It?
- Takeaways from Election Day 2025
- Controversy: Did the BBC manipulate Trump's speech?